BACKGROUND & AIMS: Data on the incidence and remission rates of non-alcoholic fatty
liver disease (NAFLD) as well as predictive factors are scant. This study aims at evaluating …

The short-term effectiveness of a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was widely …

Background & Aims Non‐alcoholic fatty liver disease ( NAFLD ) is associated with increased
cardiovascular disease ( CVD ) risk. Non‐high‐density lipoprotein cholesterol (non‐ HDL ‐C…

Retrospective studies suggest that coffee consumption may exert beneficial effects in patients
with nonalcoholic fatty liver; however, prospective data supporting a protective role on liver …

Background Waning of protection against infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) conferred by 2 doses of the BNT162b2 vaccine begins shortly …

Background Reports of waning vaccine-induced immunity against COVID-19 have begun to
surface. With that, the comparable long-term protection conferred by previous infection with …

Background: There is insufficient evidence regarding the magnitude and durability of
protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 …

Background & Aims Non‐alcoholic fatty liver disease ( NAFLD ) is suspected to confer an
increased risk for developing type 2 diabetes ( DM ). However, only a few prospective studies …

Type 2 diabetes (T2D) is associated with increased risk of Alzheimer's disease (AD). There
is evidence for impaired blood–brain barrier (BBB) in both diseases, but its role in the …

Background: Dietary advanced glycation end-products (AGEs) are linked to cognitive decline.
However, clinical trials have not tested the effect of AGEs on cognition in older adults. …